SCHEMBL7456523

SCHEMBL7456523

Nc1cnccc1C(=O)NC1CCOC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 4/20 0.50
▸ PDE10A Q9Y233 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KDM6B O15054 1/20 0.45
▸ KDM4A O75164 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ KDM4D Q6B0I6 1/20 0.45
▸ KDM4C Q9H3R0 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ TGFBR1 P36897 2/20 0.44
▸ GLA P06280 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ CSNK2A2 P19784 2/20 0.43
▸ CSNK2A1 P68400 2/20 0.43
▸ HPGDS O60760 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7461632 0.89 KDM4E (0.50) NAMPTPDE10AKDM4EALDH1A1MEN1
SCHEMBL7510470 0.84 ALDH1A1 (0.54) PDE10AKDM4EALDH1A1MEN1KDM6B
SCHEMBL7512985 0.82 ALDH1A1 (0.51) PDE10AKDM4EALDH1A1MEN1KDM6B
SCHEMBL7518032 0.82 ALDH1A1 (0.51) NAMPTPDE10AKDM4EALDH1A1MEN1
SCHEMBL13162036 0.82 NAMPT (0.50) NAMPTPDE10ATDP1TGFBR1HPGDS
SCHEMBL13162009 0.82 NAMPT (0.50) NAMPTPDE10ATDP1TGFBR1HPGDS
SCHEMBL28949389 0.81 CRBN (0.48) NAMPTKDM4EALDH1A1MEN1MAPT
SCHEMBL7515053 0.81 ALDH1A1 (0.50) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL21619325 0.76 RAB9A (0.41) NAMPTMEN1KMT2ACSNK2A2CSNK2A1
SCHEMBL23387883 0.76 ALDH1A1 (0.59) NAMPTALDH1A1MAPTL3MBTL1HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 — — EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 — — US claimed
US-8623866-B2 — — 2014-01-07 — — US claimed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 — — EP claimed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — WO claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 — — EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 — — US disclosed
US-8623866-B2 — — 2014-01-07 — — US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 — — EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A NAMPT 500/4885PDE10A 1/4885KDM4E 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback